Elanco Animal Health (ELAN) Earnings Analysis
Elanco Animal Health (ELAN) has no confirmed upcoming earnings date. Last quarter (2025-08-07) it beat with EPS 0.26 USD vs 0.2 USD est (+30%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -50.90.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ELAN next report earnings?
No confirmed upcoming earnings date is currently scheduled for ELAN. This page updates as the calendar is published.
ELAN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-07 | 0.26 USD | 0.2 USD | +30% | Beat |
| 2024-11-07 | 0.13 USD | 0.12 USD | +8.3% | Beat |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
ELAN valuation and analyst view
| Trailing P/E | -50.90 |
|---|---|
| Trailing EPS | -0.48624 USD |
| Price / book | 1.94 |
| Dividend yield | 0.00% |
| Market cap | 12.89B |
| Analyst consensus | Buy (15 buy / 4 hold / 2 sell) |
| Avg price target | 24.5 USD |
Related research pages
Frequently asked questions
When is Elanco Animal Health (ELAN)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ELAN. This page updates as the calendar is published.
Did ELAN beat earnings last quarter?
In its 2025-08-07 report, ELAN posted EPS of 0.26 USD versus a 0.2 USD estimate — a beat of 30%.
What is ELAN's earnings track record?
Over the last 2 reported quarters with consensus data, ELAN beat estimates 2 times (100%).
What is ELAN's current P/E ratio and EPS?
ELAN trades at a trailing P/E of -50.90 on trailing EPS of -0.4862366887683343 USD.
What do analysts rate ELAN?
Analyst consensus is "Buy" across 21 ratings (0 strong buy, 15 buy, 4 hold, 2 sell, 0 strong sell). Average 12-month price target: 24.5 USD.